Branched-chain alpha-keto acid dehydrogenase complex
The branched-chain α-ketoacid dehydrogenase complex (BCKDC or BCKDH complex) is a multi-subunit complex of
Biological function
In animal tissue, BCKDC catalyzes an irreversible step
The overall catabolic reaction catalyzed by the BCKDC is shown in Figure 1.
Structure
The mechanism of enzymatic catalysis by the BCKDC draws largely upon the elaborate structure of this large enzyme complex. This enzyme complex is composed of three catalytic components:
Unit | EC number | Name | Gene | Cofactor |
---|---|---|---|---|
E1 | EC 1.2.4.4 | alpha-ketoacid dehydrogenase | BCKDHA | thiamine pyrophosphate (TPP) |
E2 | EC 2.3.1.168 | dihydrolipoyl transacylase | DBT | lipoic acid, coenzyme A |
E3 | EC 1.8.1.4 | dihydrolipoamide dehydrogenase | DLD | FAD, NAD |
In humans, 24 copies of E2 arranged in octahedral symmetry form the core of the BCKDC.
The role of each subunit is as follows:
E1 subunit
E1 uses thiamine pyrophosphate (TPP) as a catalytic cofactor. E1 catalyzes both the decarboxylation of the α-ketoacid and the subsequent reductive acylation of the lipoyl moiety (another catalytic cofactor) that is covalently bound to E2.
E2 subunit
E2 catalyzes a transfer of the acyl group from the lipoyl moiety to coenzyme A (a stoichiometric cofactor).[14]
E3 subunit
The E3 component is a flavoprotein, and it re-oxidizes the reduced lipoyl sulfur residues of E2 using FAD (a catalytic cofactor) as the oxidant. FAD then transfers these protons and electrons to NAD+ (a stoichiometric cofactor) to complete the reaction cycle.
Mechanism
As previously mentioned, BCKDC's primary function in mammals is to catalyze an irreversible step in the catabolism of branched-chain amino acids. However BCKDC has a relatively broad specificity, also oxidizing 4-methylthio-2-oxobutyrate and 2-oxobutyrate at comparable rates and with similar Km values as for its branched-chain amino acid substrates.[15] The BCKDC will also oxidize pyruvate, but at such a slow rate this side reaction has very little physiological significance.[16][17]
The reaction mechanism is as follows.[18] Please note that any of several branched-chain α-ketoacids could have been used as a starting material; for this example, α-ketoisovalerate was arbitrarily chosen as the BCKDC substrate.
- NOTE: Steps 1 and 2 occur in the E1 domain
STEP 1: α-ketoisovalerate combines with TPP and is then decarboxylated. The proper arrow-pushing mechanism is shown in Figure 3.
STEP 2: The 2-methylpropanol-TPP is oxidized to form an acyl group while being simultaneously transferred to the lipoyl cofactor on E2. Note that TPP is regenerated. The proper arrow-pushing mechanism is shown in Figure 4.
- NOTE: The acylated lipoyl arm now leaves E1 and swings into the E2 active site, where Step 3 occurs.
STEP 3: Acyl group transfer to CoA. The proper arrow-pushing mechanism is shown in Figure 5.
- *NOTE: The reduced lipoyl arm now swings into the E3 active site, where Steps 4 and 5 occur.
STEP 4: Oxidation of the lipoyl moiety by the FAD coenzyme, as shown in Figure 6.
STEP 5: Reoxidation of FADH2 to FAD, producing NADH:
- FADH2 + NAD+ → FAD + NADH + H+
Disease relevance
A deficiency in any of the enzymes of this complex as well as an inhibition of the complex as a whole leads to a buildup of branched-chain amino acids and their harmful derivatives in the body. These accumulations lend a sweet smell to bodily excretions (such as ear wax and urine), leading to a pathology known as maple syrup urine disease.[19]
This enzyme is an
Mutations of the BCKDK gene, whose protein product controls the activity of the complex, may result in over-activation of the complex and excessive catabolism of the three amino acids. This leads to branched-chain keto acid dehydrogenase kinase deficiency, a rare disease first described in humans in 2012.[21]
References
- PMID 3597778.
- PMID 2649080.
- ISBN 978-0-07-182537-5.
- .
- PMID 3028049.
- PMID 4308861.
- PMID 14463994.
- PMID 10745006.
- S2CID 33210101.
- PMID 4055756.
- PMID 2188967.
- PMID 1888719.
- ^ Berg, Jeremy M., John L. Tymoczko, Lubert Stryer, and Lubert Stryer. Biochemistry. 6th ed. New York: W.H. Freeman, 2007. 481. Print.
- PMID 6652074.
- PMID 3800905.
- PMID 283398.
- PMID 6589597.
- ^ Berg, Jeremy M., John L. Tymoczko, Lubert Stryer, and Lubert Stryer. Biochemistry. 6th ed. New York: W.H. Freeman, 2007. 478-79. Print.
- S2CID 6426166.
- PMID 17657817.
- PMID 22956686.
External links
- GeneReviews/NCBI/NIH/UW entry on Maple Syrup Urine Disease
- Branched+Chain+Ketoacid+Dehydrogenase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- EC 1.2.4.4
- [1]